Objective: In patients with calcification of the ascending aorta, postoperative stroke and mortality rates remain high after conventional aortic valve replacement, but the results of trans-apical aortic valve implantation in these patients are not known. We evaluate the outcome of transapical aortic valve implantation in patients with severely calcified ascending aorta in a single center with expanded procedural experience. Methods: Between April 2008 and July 2010, 258 patients underwent trans-apical aortic valve implantation using Edwards Sapien valve. By computed tomography (CT) scan, we identified 46 (18%) patients with severe calcification of the ascending aorta (16 with porcelain aorta and 30 with severe, but not complete, calcification). Results: Of 46 patients (mean age 77 AE 10 years, range 63-90 years; EuroSCORE (European System for Cardiac Operative Risk Evaluation) 45 AE 22%; STS (Society of Thoracic Surgeons) score 23 AE 13) with calcified aorta, 15 received 23-mm valves and 31 patients 26-mm valves. Primary valve implantation was successful in 44 patients and a second valve was implanted (valve-in-valve) in two. Six patients underwent concomitant interventions (three elective percutaneous coronary intervention (PCI), one off-pump coronary artery bypass (OPCAB), one tricuspid valve reconstruction, and one left-ventricular (LV) aneurysmectomy). The final procedural results showed valve incompetence (trace or grade 1) in 17 (37%) patients and paravalvular leak in 15 (32.6%) (trace in 10 and grade 1 in five). There was no 30-day mortality. Postoperatively, cranial CT showed new cerebral ischemia areas in three patients (6.2%), but only one patient (2.1%) experienced postoperative neurological deficit (temporary aphasia). Survival at 6 and 12 months was 88% and 85.2%, respectively. Conclusions: Trans-apical aortic valve implantation can be performed safely in patients with aortic valve stenosis and severe calcification of the ascending aorta. #
Introduction
The presence of calcification in the ascending aorta is a challenge for every heart surgeon and may constitute a major problem during cardiac surgery. The scope of involvement ranges from isolated plaques to the circumferential calcification of the ascending aorta. Approximately 2% of patients requiring cardiac surgery and one-third of patients older than 80 years have severe (significant) calcification of the ascending aorta. One-fifth of these patients will present with extreme diffuse, circumferential, plate-like calcification of the proximal aorta, so-called 'porcelain aorta' [1, 2] . Conventional aortic valve replacement (AVR) in these patients requires cardiopulmonary bypass, cross-clamping and manipulation of the ascending aorta, which markedly increase the risk of cerebral embolization and cerebrovascular accident [3] . A modification of the surgical technique is necessary to avoid manipulation of the aorta and the associated high risk of cerebral embolization, aortic dissection, and mural laceration. Different techniques, including hypothermic circulatory arrest, apico-aortic conduit, local endarterectomy, and total replacement of the ascending aorta have been used. The purpose of these strategies is to avoid any manipulation of the ascending aorta and thus avoid atheroembolism. Despite these techniques, the rates of postoperative stroke and mortality remain high [4, 5] .
Trans-catheter aortic valve implantation is a therapeutic alternative for high-surgical-risk patients with severe symptomatic aortic stenosis [6] [7] [8] . Two models of prosthesis are currently commercialized in Europe, which can be implanted either via a trans-arterial or a trans-apical approach. The procedure has nowadays been introduced in many centers although performed in vivo already in 1989 [9] . It offers some possible advantages over conventional valve replacement, especially in patients with severely calcified ascending aorta or porcelain aorta. The trans-catheter aortic valve implantation is an off-pump technique without manipulation of the aorta, which may be an alternative to other known techniques, and used in patients with calcified aorta.
The objective of this article is to evaluate the outcome of the TAVI technique in very high-risk and elderly patients with stenotic aortic valve and severe calcification of the aorta.
Material and methods
Between April 2008 and 31 July 2010, 258 consecutive high-risk patients with severe aortic valve stenosis underwent trans-apical valve implantation. The procedure was performed in multimorbid patients with symptomatic severe aortic valve stenosis (logistic EuroSCORE (European System for Cardiac Operative Risk Evaluation) 20% or higher and/or STS (Society of Thoracic Surgeons) score 10% or higher). Patients with lower risk scores were considered for transapical valve implantation only for clear surgical reasons, for example, 'porcelain aorta'. Active valve endocarditis and an aortic annulus diameter of more than 24 mm were the only exclusion criteria for the procedure. Severe co-morbidity was not an exclusion criterion. The preoperative examinations included clinical and laboratory examinations, electrocardiography, chest X-ray, coronary angiography, transthoracic echocardiography, ultrasound examinations (Doppler) of the peripheral arteries and carotid arteries, cranial computed tomography (CT), and CT scan of the chest and pelvis followed by vascular three-dimensional (3D) reconstruction. The CT scan of the chest allows visualization of the morphology of the aortic root, and more important measurement of the distance between the ostium of the coronary arteries and the aortic annulus.
Study population
The calcification in the ascending aorta was evaluated according to preoperative CT scan findings with the following grading: grade 0, no calcification; grade 1, mild calcification; grade 2, moderate focal calcification; grade 3, severe but not circumferential calcification; and grade 4, circumferential calcification, that is, porcelain aorta. By preoperative CT scan, we identified 46 (18%) patients with severely calcified ascending aorta (grades 3 and 4). There were 16 patients with porcelain aorta (Fig. 1 ) and 30 patients with severe but not circumferential aortic calcification. The patients' demographic data, the preoperative findings, and laboratory values of this subgroup of patients are shown in Table 1 . There were 31 women and 15 men with a mean age of 77 AE 10 years (range 63-90 years). Mean logistic EuroSCORE and mean STS score were 45 AE 22% and 23 AE 13, respectively. Thirteen patients had had previous cardiac operations (four coronary artery bypass grafting (CABG), two AVRs, three combined AVR and CABG, one mitral valve replacement (MVR), one mitral valve commissurotomy, one combined AVR (homograft) and MVR, and one lung transplantation). In one patient, additional severe tricuspid valve incompetence was present. Three patients were in cardiogenic shock preoperatively. The patients were operated on after informed consent was obtained from them or their representatives.
Surgical technique
All surgical procedures were performed in our hybrid operating room in a completely sterile environment and under fluoroscopic imaging with a monoplane angiography system. All patients received balloon-expandable transcatheter stent-prosthetic xenograft valves of 23-or 26 mm diameter with their delivering system (both Edwards SAPIEN THV, Edwards Lifesciences, Irvine, CA, USA). The size of the valve used was determined according to the diameter of the native aortic valve annulus as measured by intra-operative transesophageal echocardiography (TEE). The original pro- [ ( ) T D $ F I G ] cedure and our modification have been described elsewhere [10, 11] . After our first experiences with the original technique, we modified the procedure and added angiographic visualization of the aortic root, aortic annulus, and the ostia of the coronary arteries during valve deployment (Fig. 2) . Because of calcification of the aorta, special attention was given to manipulation of the guide wire to avoid embolization. To reduce manipulation in the ascending aorta and aortic arch, we tried to avoid any erroneous manipulation with a guide wire in supraaortic vessels. Furthermore, gentle insertion of a 14F sheath above the aortic valve was performed to avoid mobilization of any atherosclerotic plaque from the wall of the ascending aorta. The procedure was monitored by fluoroscopy, angiography, and intraoperative TEE.
Results

Procedural, early, and late outcomes
The primary implantation of the valve was successful in all but two patients who additionally received a second valve (valve-in-valve). There was no conversion to conventional surgery. There was no procedural mortality and no mortality in the 30 days after surgery. The survival rate at 1, 6, and 12 months was 100%, 88%, and 85.2%, respectively. A total of six patients died during the follow-up period. The mean logistic EuroSCORE of patients, who died during follow-up, was 59.5 AE 13.8%, ranging from 37.1% to 79.3%. The late deaths were due to pneumonia (two), septicemia (two), multi-organ failure (one), and unknown cause (one).
Intra-operative course and complications
According to the preoperative measurement of the annulus by TEE, in 15 patients a 23-mm valve and in 31 patients a 26-mm valve was implanted. During the same procedure, in two patients (4.3%) a second valve (valve in valve) was implanted to treat severe valve regurgitation; in one patient, a valvular cusp dysfunction occurred, and, in the second, central regurgitation after re-dilatation of the valve to treat a significant paravalvular leak. The valve implantation in patients with previously implanted biological valve prosthesis was successful and without complications. Intraoperative echocardiographic data showed a significant decrease of mean aortic gradient and a significant increase of aortic valve area, from 44.1 AE 15 mmHg to 5.8 AE 2.8 mmHg and from 0.68 AE 0.24 cm 2 to 1.6 AE 0.43 cm 2 , respectively. At the end of the procedure, 29 (63%) patients had no signs of aortic valve incompetence, 10 (21%) minimal paravalvular leak, and five (10%) paravalvular regurgitation grade 1. In two patients, the procedure was performed using elective femorofemoral cardiopulmonary bypass because of poor left-ventricular function and in one patient due to planned concomitant procedures (tricuspid valve reconstruction). Six patients simultaneously underwent additional elective procedures to aortic valve implantation: three coronary stentings, one off-pump coronary artery bypass (OPCAB), one left-ventricular aneurysmectomy, and one tricuspid valve reconstruction due to tricuspid valve regurgitation grade 4 and right-sided heart failure. In patients who required OPCAB and tricuspid valve reconstruction, the valve implantation was performed via a sternotomy. There was no periprocedural or postoperative aortic dissection, no new or increased mitral valve regurgitation, and no valve dislocation. No patients needed postoperative surgical revision because of bleeding. Postoperatively, in one patient, a small apical pseudo-aneurysm was detected in the CT scan. It was closed successfully through the previous mini-left-thoracotomy without need for cardiopulmonary bypass. One patient needed femoro-popliteal bypass because of severe peripheral arterial disease in the postoperative course. Two patients (4.3%) required pacemaker implantation because of postoperative atrioventricular (AV) block of grade 3.
Neurological outcome
Preoperative clinical neurological examination and cranial CT imaging revealed the diagnosis of old single or multiple cerebral emboli or infarcts in eight patients (17.4%). Postoperatively, cranial CT showed new cerebral ischemia areas in three patients (6.2%), but only one patient (2.1%) experienced conspicuous postoperative neurological deficits. This patient had temporary aphasia. In two other patients, no clinical signs of cerebral embolism were found postoperatively.
Discussion
Our early experience with trans-catheter valve implantation in patients with severe calcification of the ascending aorta showed that the procedure might have significant advantages in comparison to other conventional techniques. Trans-apical aortic valve implantation was performed safely and easily in all patients with severely calcified ascending aorta. There was no mortality and only one patient (out of 46) had a postoperative neurological event (transient aphasia).
Severely calcified ascending aorta in cardiac surgery patients poses a serious dilemma for the surgeon due to the fact that it may preclude safe cannulation and crossclamping and constitute difficulties for aortotomy and suturing. Furthermore, severe aortic atherosclerosis represents a serious problem due to a significant risk of cerebral embolization, aortic dissection, and mural laceration by manipulation and clamping manoeuvres [12] . Several techniques have been proposed to manage various aspects of these problems and to minimize the risk of cerebral embolization, including aortic endarterectomy [13] , total replacement of the ascending aorta [4, 14] , profound hypothermic circulatory arrest [15] , endoaortic balloon occlusion [16] , and apico-aortic conduit [17] . However, each of these methods has disadvantages and no standard treatment has emerged to date. All these strategies have a higher risk of postoperative stroke and mortality.
Despite several co-morbidities and higher risk score for conventional surgery (as defined by the logistic EuroSCORE and the STS score), we observed no early mortality. The stroke rate (2.1%) also was significantly lower than the stroke rate after conventional techniques used in patients with severely calcified aorta reported in the literature [3, 18] . The prevalence of porcelain aorta in patients undergoing trans-catheter aortic valve implantation has been reported to vary widely between 5% and 33%, depending on definition and diagnostic methods [19, 20] . Up to now, only one study has been published regarding the evaluation of trans-catheter valve implantation and late outcomes in this subgroup of patients [21] . This multicenter Canadian study reported an early mortality rate of 11.5% and a stroke rate of 1.6% in 61 patients. Rates of need of second valve and conversion to open heart surgery were 6.6% and 3.2%, respectively. In our study, no patient needed conversion to open heart surgery and the rate of second valve was 4.3% (two patients). Against the reported reasons for second valve in the Canadian study (e.g., valve malposition due to difficulty in valve positioning or valve displacement during balloon inflation), the reasons for second valve in our patients were valvular cusp dysfunction and re-dilatation of the valve to treat paravalvular leakage resulting in central regurgitation. Especially in a severely calcified aorta, both valve malposition and valve displacement during balloon inflation can be minimized or avoided using the 'Berlin addition' with angiographic visualization during valve deployment [9] . Although this patient subgroup has a high risk for cerebral embolism, only one patient (2.1%) experienced a stroke with postoperative temporary aphasia. Compared with other surgical techniques, this stroke rate is very low and therefore acceptable. Our results in this subgroup of high-risk patients are similar to the results of patients without calcification of the aorta, who underwent trans-apical valve implantation in our institution [22] . We observed a 6-month survival rate of 88% and 1-year survival rate of 85.2%, which shows that these patients have a low mortality in follow-up. According to the survival rate, there was no statistically significant difference between patients with severe calcification of the aorta and those without calcification (Fig. 3) .
The other methods of trans-catheter valve implantation (transfemoral or trans-axillary) have disadvantages compared with trans-apical access, especially in patients with severely atherosclerotic ascending aorta and aortic arch. The insertion of the guide wire and the delivery system should be performed from the retrograde direction in the transfemoral approach. The advancing of the guide wire through the stenotic and calcified aortic valve is an important step, and can be difficult in some patients; several attempts may be needed during the procedure. These characteristics of the transfemoral (or trans-axillary) valve implantation with the possibility of frequent guide-wire manipulation in the ascending aorta and the insertion of the delivery system through the aortic arch and ascending aorta in patients with atherosclerotic aorta can often lead to plaque mobilization, and thus to cerebral embolization, and, in some cases, to aortic or coronary artery dissection. For this reason, in our opinion, trans-apical aortic valve implantation should be accomplished in patients with atherosclerotic aorta. The higher incidence of neurological morbidity after the transfemoral approach compared with the trans-apical approach, reported in the literature, is an important reason to use the trans-apical approach in these patients, who have a high risk for cerebral embolism. The Placement of AoRTic TraNscathetER Valve (PARTNER) trial reported a stroke rate of 6.7% in 179 patients treated with the transfemoral approach. In this series, there were 34 patients (19%) with extensively calcified aorta [23] . Similar and/or higher rates of stroke after transfemoral aortic valve implantation are reported in other published articles [24, 25] .
Although our team is well versed in all three techniques, we deliberately performed trans-apical valve implantation in these patients to minimize the risk of embolism. The trans-apical approach is an antegrade, direct procedure and the guide wire can be inserted through the valve more easily and rapidly in comparison to the retrograde approach. The procedure is independent of peripheral vascular disease, which is presented with high incidence in patients with atherosclerotic aorta. Despite these advantages, cerebral embolism due to plaque mobilization, aortic dissection, and valve dislocation and annulus rupture due to rigid aortic annulus and aortic wall remain common complications during trans-apical valve implantation. To minimize or to avoid these complications, special attention should be given during insertion of the guide wire to avoiding manipulation in the ascending aorta and aortic arch. The choice of valve size for these patients is very important, as an aggressive oversizing can lead to annulus rupture due to rigid aortic annulus and should be avoided. Furthermore, the balloon valvuloplasty and valve deployment should be performed under angiographic visualization, assessing the relationship between the new valve and the aortic wall with slow and gradual balloon inflation, and not always fully expanded balloon. Despite this restriction during valve deployment, the rate of paravalvular leakage observed in this study group is very low und comparable with that in our patients without severely calcified ascending aorta [22] .
In conclusion, our early experience with trans-catheter valve implantation demonstrates significant advantages in comparison to other conventional techniques in the setting of severe aortic calcification. In patients with aortic valve stenosis and severe calcification of the ascending aorta, trans-apical aortic valve implantation can be performed safely and with a very low incidence of neurological events and mortality. This procedure should be considered as the first therapy in these patients.
